Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. - Wikidata - wikimedia - TriplyDB

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

http://www.wikidata.org/entity/Q37926278

about

Interventions for renal vasculitis in adults Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.Peripheral neuropathies in rheumatic disease--a guide to diagnosis.Diagnosis and therapeutic options for peripheral vasculitic neuropathy.Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort.Peroneal nerve involvement as initial manifestation of primary systemic vasculitis.Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.The nonsystemic vasculitic neuropathies.Factors that predict in-hospital mortality in eosinophilic granulomatosis with polyangiitis.The characterisation and determinants of quality of life in ANCA associated vasculitis.Peripheral neuropathy as initial manifestation of primary systemic vasculitides.Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis (AAV) Restricted to the Limbs: A Case Report.Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.

P2860

Q24187038-D0CC2463-0F9C-44D6-836F-013DFB66AD9A Q36104863-B511E1AD-7795-4778-B6C1-381E337BB85A Q36484399-65E9B325-62B0-434E-91CA-A436857929F5 Q38036106-B1DC0689-C476-4582-9A9C-15E8A2F57CB5 Q38398833-6DB2D699-7414-47B0-98D3-D56CD621BE1B Q38571610-A37183A6-4E30-4455-83C9-D1858B224345 Q38614076-DB0B62A6-1D82-4C35-B1C5-83B84EC914E9 Q38965278-3D76FB55-5BAE-4724-BAC3-D3B8E7E98CC3 Q39266532-D3A3A938-5D5D-40EB-9FE4-C1BF564207F5 Q41373236-822047C1-EDE4-4EFC-90EA-8CCDC1BB4C96 Q43524663-25034EA5-FC28-4E09-BA5A-E8F8B1DCEE1E Q45282440-17776067-9879-48BB-BEB9-C5D79A38D720 Q49567268-4212BB5F-3210-49C1-81E5-24144AE0BE4C Q51167941-1588348E-8C84-4BB1-B591-DA1D1196FB24

P2860

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

http://www.wikidata.org/entity/Q37926278

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@en

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@nl

type

label

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@en

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@nl

prefLabel

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@en

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials.

@nl

P1433

Q37926278-78320129-F2A6-40C5-BC11-7D65399C5C2B

P1476

Q37926278-B94D9692-0614-433F-9AD7-A1184E5CB6CD

P2093

Q37926278-1CC190CE-A1C4-4624-B586-F30096C67E1E

Q37926278-39BDBFCA-17AF-46F2-887D-E6EBCFC7B7F0

Q37926278-4574EE8B-52C7-462A-A843-F57C734EC063

Q37926278-612266FA-37CD-4BF3-B0F7-4F04FA8C372F

Q37926278-8B51450F-236C-438D-B564-799081BDC640

Q37926278-ED8A96ED-D328-4752-B7AC-FE78B1C1F264

Q37926278-F3627842-86CF-483D-AE75-34565C41B960

P2860

Q37926278-01F4C564-4D28-44BC-9032-3C1D0FA97A6D

Q37926278-1368018F-A850-4E25-8D8D-F10CAFB7233D

Q37926278-1EAFD681-E6CA-4F1F-BE7C-FF13D1E79AE0

Q37926278-3C10502C-F364-4411-97EB-D1FECAC0BCF0

Q37926278-46CFE711-3439-44C2-A2B2-93D3C6A6316D

Q37926278-471B7B0D-98C8-4D8D-9768-953BD618A13D

Q37926278-7CD848F2-7978-4653-8D04-D08211520C18

Q37926278-91C621AA-B6AF-4298-A267-91C7692EC1F5

Q37926278-C2B4B12D-CB69-4179-8A42-979D8EEC5A2A

Q37926278-C4222DC1-F877-4537-A422-7D18704F849D

P304

Q37926278-8D3BAAC9-9E44-4FB3-8DAE-D9258D9912E6

P31

Q37926278-C27F201A-321C-4646-81F6-012BB5A163A3

P356

Q37926278-7C052C5A-6B23-474E-8C6A-5386628287CF

P433

Q37926278-9A1D2174-9095-403C-BDFD-5CA4B2046E33

P478

Q37926278-20CAB8BB-BCE7-4B28-9B2D-C44505BC7A4C

P50

Q37926278-4F6F28F8-2DC9-41BD-8963-876DDA5007F9

Q37926278-6CF1C7C1-6F44-4F71-ADBF-F1E214414815

P577

Q37926278-DB4EA3AA-0FB0-4853-838E-B154382123D1

P698

Q37926278-F9DB383D-0D93-4EEB-ACCF-EB68F0A09FCD

P356

P1433

P1476

Peripheral neuropathy in ANCA- ...... Vasculitis Study Group trials

@en

P2093

David R W Jayne

http://www.w3.org/2001/XMLSchema#string

European Vasculitis Study Group

http://www.w3.org/2001/XMLSchema#string

Loic Guillevin

http://www.w3.org/2001/XMLSchema#string

Michael P Collins

http://www.w3.org/2001/XMLSchema#string

Nigel K Arden

http://www.w3.org/2001/XMLSchema#string

Ravi Suppiah

http://www.w3.org/2001/XMLSchema#string

Robert D M Hadden

http://www.w3.org/2001/XMLSchema#string

P2860

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Prompt plasmapheresis successfully rescue pulmonary-renal syndrome caused by ANCA-negative microscopic polyangiitis.

Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.

Standardized neurologic evaluations of 128 patients with Wegener granulomatosis.

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis.

Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Wegener's Granulomatosis vasculitis and granuloma.

P304

2214-2222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KER266

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Raashid Ahmed Luqmani

P577

2011-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21890618

http://www.w3.org/2001/XMLSchema#string